Evidence map›Paper›PMID 34544952›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Acute Tubulointerstitial Nephritis in Rosai-Dorfman Disease Mimicking IgG4-related Disease.

Satoshi Kurahashi, Naohiro Toda, Masaaki Fujita, Katsuya Tanigaki, Jun Takeoka, Hisako Hirashima, Eri Muso, Katsuhiro Io, Takaki Sakurai, Toshiyuki Komiya

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Satoshi KurahashiDepartment of Nephrology, Kansai Electric Power Hospital, Japan.
Naohiro TodaDepartment of Nephrology, Kansai Electric Power Hospital, Japan.
Masaaki FujitaDepartment of Rheumatology, Kansai Electric Power Hospital, Japan.
Katsuya TanigakiDepartment of Nephrology, Kansai Electric Power Hospital, Japan.
Jun TakeokaDepartment of Nephrology, Kansai Electric Power Hospital, Japan.
Hisako HirashimaDepartment of Nephrology, Kansai Electric Power Hospital, Japan.
Eri MusoDepartment of Nephrology, Kansai Electric Power Hospital, Japan.
Katsuhiro IoDepartment of Hematology, Kansai Electric Power Hospital, Japan.
Takaki SakuraiDepartment of Diagnostic Pathology, Kansai Electric Power Hospital, Japan.
Toshiyuki KomiyaDepartment of Nephrology, Kansai Electric Power Hospital, Japan.
Kansai Electric Power Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosai-Dorfman-Destombes disease (RDD) is a non-Langerhans cell histiocytosis characterized by the accumulation of histiocytes inside the lymph nodes or extranodally. The association between RDD and IgG4-related disease (IgG4-RD) is discussed. We herein report a case of RDD manifesting as acute tubulointerstitial nephritis mimicking IgG4-RD. The first renal biopsy showed severe tubulointerstitial nephritis with infiltration of S100-positive histiocytes and IgG4-positive plasma cells; storiform fibrosis and obliterative phlebitis were not confirmed. After prednisolone therapy, IgG4-positive cells and S100-positive histiocytes were decreased, but the IgG4/IgG ratio increased despite clinical improvement. These findings indicated extranodal RDD in the kidney presenting as tubulointerstitial nephritis.

Indexed as

Histiocytosis, SinusImmunoglobulin G4-Related DiseaseNephritis, InterstitialHumansPlasma CellsIgG4-related diseaseRosai-Dorfman diseasetubulointerstitial nephritis

Identifiers

PMID34544952
PMCPMC9038462
OpenAlexW3199266583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.